Martingale Asset Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Martingale Asset Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-101,566	Closed	-$677K	–	864
2023 Q3	$677K	Buy	101,566 +22	+0%	+$183	0.01%	544
2023 Q2	$920K	Buy	101,544 +16,134	+19%	+$142K	0.02%	470
2023 Q1	$621K	Buy	+85,410	New	+$634K	0.01%	565

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Martingale Asset Management's PNT Position: Q4 2023 in Review

Martingale Asset Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 101,566 shares — an estimated $677K sold.

Martingale Asset Management first reported a position in PNT in Q1 2023 and held it in 3 quarters. The position peaked at $920K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Martingale Asset Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Martingale Asset Management sold 101,566 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $677K.
Martingale Asset Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Martingale Asset Management's POINT Biopharma Global Inc. Common Stock position peaked at $920K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Martingale Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.